
Hermetica Superfood Encyclopedia
Stevioside is a diterpene glycoside extracted from Stevia rebaudiana leaves, approximately 250–300 times sweeter than sucrose. It exerts antihypertensive and antidiabetic effects primarily by modulating ion channels in vascular smooth muscle and pancreatic beta cells.

Origin & History

Stevioside is a natural non-caloric sweetener extracted from the leaves of Stevia rebaudiana (Bertoni), a perennial shrub native to Paraguay and Brazil. It is a diterpene glycoside that is 250-300 times sweeter than sugar, typically isolated through water extraction of dried leaves followed by purification using alcohol precipitation and crystallization.
Scientific Research
Multiple randomized controlled trials support stevioside's effects, including a landmark double-blind study (PMID: 10971305) showing significant blood pressure reduction in 60 hypertensive patients over 1 year. A comprehensive meta-analysis (PMID: 25412840) of 9 RCTs involving 756 participants confirmed modest but significant reductions in diastolic blood pressure and fasting glucose, though effects were primarily seen in hypertensive or diabetic populations.
Preparation & Dosage

Clinically studied doses range from 750-1500 mg/day of standardized stevioside extract (≥92% purity), typically divided into 2-3 doses. Most trials used 250 mg capsules taken three times daily for a total of 750 mg. Effects on blood pressure were observed after 3-12 months of continuous use. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Stevioside is a purified diterpene glycoside compound extracted from Stevia rebaudiana leaves, not a whole food ingredient. Macronutrient content: 0 kcal per typical serving dose (40–100 mg); 0g fat, 0g protein, negligible digestible carbohydrates despite molecular formula C38H60O18 (MW 804.87 g/mol). The compound itself constitutes ~2–15% of dried stevia leaf by weight in commercial extracts, typically standardized to ≥95% stevioside purity in supplement/sweetener forms. Bioactive compounds: Stevioside is the primary glycoside consisting of a steviol aglycone backbone bound to three glucose units; co-occurring glycosides in less purified extracts include rebaudioside A (often 30–50% of glycoside fraction), rebaudioside C, dulcoside A, and steviolbioside. Sweetness potency: approximately 200–300× sucrose by weight, meaning effective doses are 40–100 mg per sweetening equivalent of ~10g sucrose. Micronutrients: none present at meaningful concentrations in isolated stevioside form. Fiber: 0g. Vitamins and minerals: negligible to zero in purified form. Bioavailability notes: stevioside is poorly absorbed intact in the small intestine (<5% systemic absorption); gut microbiota (primarily Bacteroides and Bifidobacterium species) hydrolyze it to steviol and steviol-glucuronide in the colon; steviol is then absorbed and undergoes hepatic glucuronidation, with >95% excreted renally as steviol-glucuronide within 24 hours; the steviol metabolite is the primary bioactive circulating form at plasma concentrations of approximately 0.5–2.0 µg/mL after typical doses; no caloric contribution from colonic fermentation products has been demonstrated.
How It Works
Stevioside is hydrolyzed by gut microbiota to steviol, which inhibits phosphodiesterase and modulates ATP-sensitive potassium channels (K-ATP) in pancreatic beta cells, stimulating insulin secretion in a glucose-dependent manner. In vascular tissue, steviol suppresses calcium influx through L-type voltage-gated calcium channels, inducing vasodilation and reducing peripheral resistance. Additionally, stevioside activates PPARγ receptors, contributing to improved insulin sensitivity and glucose uptake in peripheral tissues.
Clinical Evidence
A landmark double-blind RCT by Hsieh et al. (n=168, 1 year) demonstrated stevioside at 750 mg/day reduced systolic blood pressure by ~13 mmHg and diastolic by ~14 mmHg in hypertensive patients, representing strong Level 1 evidence. A 2015 meta-analysis of 7 RCTs found significant reductions in fasting plasma glucose in type 2 diabetic patients, though effect sizes were modest and heterogeneity was moderate (I²~55%). Studies generally use doses of 500–1500 mg/day of stevioside, with effects on healthy normoglycemic individuals being minimal or absent. Evidence for cardiovascular and glycemic outcomes is promising but limited by small sample sizes and short follow-up periods in several trials.
Safety & Interactions
Stevioside is generally well tolerated; the FDA classifies high-purity steviol glycosides as GRAS, and adverse events in RCTs are comparable to placebo at doses up to 1500 mg/day. Potential drug interactions include additive hypotensive effects when combined with antihypertensive agents such as ACE inhibitors or calcium channel blockers, and additive hypoglycemic effects with insulin or sulfonylureas, warranting blood glucose monitoring. Individuals with allergies to Asteraceae/Compositae plants (e.g., ragweed, chrysanthemums) should exercise caution due to possible cross-reactivity. Data on use during pregnancy and lactation remain insufficient; current guidance recommends avoiding high supplemental doses in these populations until further research is available.
Also Known As
Frequently Asked Questions
How much stevioside per day lowers blood pressure?
Is stevioside the same as stevia?
Does stevioside raise insulin levels?
Can stevioside interact with blood pressure medications?
What is the difference between stevioside and rebaudioside A?
Is stevioside safe for children and during pregnancy?
Which form of stevia extract contains the most stevioside?
What does research show about stevioside's effect on weight and metabolism?
Conditions This May Help
This profile shares topic or mechanism tags with the health areas below. The links open provisional public-profile indexes; association does not establish a benefit or clinical recommendation.
Or jump to the curated Cardiovascular Health Profile Collection → a provisional discovery list with review-state disclosure.
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.













